2nd Quarter - Report

RED+BLUE STRATEGIES for MCGOVERN AND ASSOCIATES

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to independent inventors and opportunities regarding the repurposing of biologics. H.R. 4287/S. 2150 - Independent Innovator Repurposing Act - focused on ensuring that independent researchers and physicians are able to see through repurposing research for certain biologic medications.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4287 (113th), S. 2150 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.